Zhiwei Huang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Top Venues

Pharmaceuticals (Basel, Switzerland)

Antimicrobial agents and chemotherapy

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiwei Huang, Lei Zhang, Yan Li, Yimin Yu, Yifeng Shen, Xiujia Sun, Kun Lou, Hongmei Luo, Zhibin Meng, Huafang Li, Yumei Wei
Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in Schizophrenia. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Zhiwei Huang, Lei Zhang, Yan Li, Yimin Yu, Yifeng Shen, Xiujia Sun, Kun Lou, Hongmei Luo, Zhibin Meng, Huafang Li, Yumei Wei
Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in Schizophrenia. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Yimin Yu, Jingjing He, Zhiwei Huang, Yan Li, Ying Wu, Yifeng Shen, Yanling Zhou, Cungang Bao, Zhiping Jin, Huafang Li
Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administration. Expert opinion on investigational drugs (2023)
Zhiwei Huang, Xinyi Yang, Yi Jin, Jicheng Yu, Guoying Cao, Jingjing Wang, Yingying Hu, Jingyi Dai, Jufang Wu, Qiong Wei, Yan Tian, Shuyan Yu, Xu Zhu, Xiaomeng Mao, Wei Liu, Hong Liang, Shansong Zheng, Yunfei Ju, Zenghua Wang, Wanzhen Li, Xiaojie Wu
First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects. Antimicrobial agents and chemotherapy (2023)